Utility of Historical Data Compared to Lead-in Response in Predicting Sustained Virologic Response in Non-Responders and Relapsers to Peginterferon/Ribavirin When Re-Treated With Boceprevir+Peginterferon Alfa-2B/Ribavirin (PR)

Authors :: Eric Lawitz
Navdeep Boparai
Stefan Zeuzem
Bruce R. Bacon
Clifford A. Brass
Janice K. Albrecht
Rafael Esteban
Patrick Marcellin
Stuart C. Gordon
Margaret Burroughs
John M. Vierling
Fred Poordad
Source :: Gastroenterology. 140:S-944
Publication Year :: 2011
Publisher :: Elsevier BV, 2011.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
Ribavirin
Gastroenterology
PEGINTERFERON/RIBAVIRIN
chemistry.chemical_compound
Non responders
chemistry
Internal medicine
Virologic response
Boceprevir
Medicine
Peginterferon alfa-2b
business
Lead (electronics)
medicine.drug

Tools